4//SEC Filing
Erlander Mark 4
Accession 0001628280-23-008354
CIK 0001213037other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:41 PM ET
Size
5.6 KB
Accession
0001628280-23-008354
Insider Transaction Report
Form 4
Erlander Mark
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2023-03-15+482,064→ 1,664,477 totalExercise: $1.72Exp: 2033-03-15→ Common Stock (482,064 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.
Documents
Issuer
Cardiff Oncology, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001651537
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:41 PM ET
- Size
- 5.6 KB